SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of September 25, 2023, by and between Ainos, Inc., a Texas corporation (the “Company”), and Lind Global Fund II LP, a Delaware limited partnership (the “Investor”).
ContractNote Agreement • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionTHIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.
SECURITY AGREEMENTSecurity Agreement • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2023 Company IndustrySECURITY AGREEMENT (this "Agreement"), dated as of September 28, 2023, by and between AINOS, INC., a Texas corporation (the "Company") and LIND GLOBAL FUND II LP, a Delaware limited partnership (the "Secured Party").
ContractWarrant Agreement • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2023 Company IndustryTHIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
Mr. Chun-Hsien Tsai Chairman and Chief Executive Officer Ainos, Inc.Placement Agent Agreement • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2023 Company Industry Jurisdiction
PLACEMENT AGENT WARRANT AINOS, INC.Placement Agent Warrant • September 29th, 2023 • Ainos, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2023 Company IndustryTHIS PLACEMENT AGENT WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, [Maxim Group LLC/Brookline], or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________, 2024 (the “Initial Exercise Date”) and prior to 5:00 p.m. (New York time) on ___________, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from AINOS, INC., a Texas corporation (the “Company”), ______ shares of common stock, par value $0.01 per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).